Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2020
Concerto Biosciences is pioneering the discovery of microbial products through its innovative k Chip discovery engine, which allows for the simultaneous construction and analysis of millions of defined microbial communities. The company focuses on developing transformative microbial, prebiotic, and postbiotic products, particularly in the context of its clinical trial for ENS-002, a microbiome-based therapy for atopic dermatitis. By harnessing the power of microbial ecology, Concerto aims to create safe and effective products that protect health and enhance the environment, positioning itself as a leader in the emerging field of microbial technologies.
Something looks off?